ISOGEN SRL facilitates access to essential radiopharmaceutical products used in PET-CT diagnostic imaging, through collaborations with established European manufacturers.
Building a reliable and efficient supply chain for nuclear medicine products across Romania.
Distribution of essential PET tracers to medical centers across Romania.
Specialized logistics for radioactive medicinal products with short half-lives.
Direct partnerships with nuclear medicine and PET-CT diagnostic centers.
Building reliable distribution networks for oncological diagnostics.
ISOGEN SRL was established with the objective of supporting the development of nuclear medicine infrastructure in Romania through the reliable distribution of radiopharmaceutical products.
The company focuses on facilitating access for Romanian medical institutions to high-quality PET tracers manufactured in compliance with European pharmaceutical standards.
Distribution activities are organized in accordance with the regulatory requirements governing pharmaceutical products and radioactive materials.
ISOGEN aims to become a reliable distribution partner for nuclear medicine centers by ensuring consistent access to essential diagnostic radiopharmaceuticals.
Distribution of PET radiopharmaceuticals to medical institutions
Development of efficient logistics solutions for short-lived tracers
Cooperation with European GMP-certified radiopharmaceutical manufacturers
Supporting the continued development of nuclear medicine services in Romania
Our portfolio includes widely used PET tracers employed in oncological diagnostics and disease monitoring.
Fluorodeoxyglucose - the most commonly used radiopharmaceutical in PET-CT imaging, playing a central role in modern oncological diagnostics.
Primarily used in PET-CT imaging for the evaluation of prostate cancer, particularly in the detection of biochemical recurrence following primary treatment.
Increasingly used in PET-CT diagnostics for prostate cancer, offering high sensitivity in identifying metastatic disease and recurrent tumors.
Radiopharmaceutical distribution requires specialized logistics adapted to the specific characteristics of radioactive medicinal products.
PET tracers have very short physical half-lives, which makes precise coordination of production, transportation and delivery essential.
ISOGEN coordinates logistics solutions designed to ensure the rapid and secure transport of radiopharmaceuticals to PET-CT centers throughout Romania.
These procedures ensure that products reach medical institutions safely and within the timeframes required for clinical use.
European regulations governing the transport of radioactive materials
Good Distribution Practice (GDP) standards for pharmaceutical products
Requirements of national nuclear and pharmaceutical regulatory authorities
ISOGEN collaborates with established European radiopharmaceutical manufacturers and with medical institutions specializing in nuclear medicine.
The company's partnerships are focused on developing a reliable supply chain for PET radiopharmaceuticals used in diagnostic imaging.
Through these collaborations, ISOGEN contributes to improving access to advanced nuclear medicine diagnostics for patients and healthcare providers in Romania.
For inquiries regarding radiopharmaceutical distribution and partnership opportunities.